High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice

Nature Biotechnology
D M FishwildN Lonberg

Abstract

Human immunoglobulin transgenic mice provide a method of obtaining human monoclonal antibodies (Mabs) using conventional hybridoma technology. We describe a novel strain of human immunoglobulin transgenic mice and the use of this strain to generate multiple high-avidity human sequence IgG kappa Mabs directed against a human antigen. The light chain transgene is derived in part from a yeast artificial chromosome clone that includes nearly half of the germline human V kappa region. In addition, the heavy-chain transgene encodes both human mu and human gamma 1 constant regions, the latter of which is expressed via intratransgene class switching. We have used these animals to isolate human IgG kappa Mabs that are specific for the human T-cell marker CD4, have high binding avidities, and are immunosuppressive in vitro. The human Mab-secreting hybridomas display properties similar to those of wild-type mice including stability, growth, and secretion levels. Mabs with four distinct specificities were derived from a single transgenic mouse, consistent with an extensive diversity in the primary repertoire encoded by the transgenes.

References

Apr 1, 1992·European Journal of Immunology·A Lautner-RieskeH G Zachau
Sep 1, 1992·Clinical Immunology and Immunopathology·P MorelJ P Revillard
Jun 1, 1991·Blood Reviews·S J Rosenfeld, N S Young
May 1, 1991·European Journal of Immunology·M BrüggemannT H Rabbitts
Aug 1, 1991·European Journal of Immunology·W PargentH G Zachau
Feb 1, 1991·Arthritis and Rheumatism·G HorneffJ R Kalden
May 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·Z LarinH Lehrach
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M BrüggemannM S Neuberger
Jun 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A F LoBuglioM B Khazaeli
Dec 19, 1987·Lancet·C HerzogW Müller
May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A M StallL A Herzenberg
Feb 1, 1985·The Journal of Experimental Medicine·D Wofsy, W E Seaman
Aug 8, 1985·The New England Journal of Medicine
Jan 1, 1968·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·W D HeissH Tschabitscher
Jan 1, 1995·International Reviews of Immunology·N Lonberg, D Huszar
Apr 25, 1994·Nucleic Acids Research·S D WagnerM Brüggemann
Oct 1, 1993·Arthritis and Rheumatism·P A van der LubbeG Riethmüller
Nov 1, 1993·European Journal of Immunology·C HuberH G Zachau
Mar 1, 1993·International Immunology·M R DalesandroG Riethmuller
Jan 1, 1993·Advances in Immunology·M C Miceli, J R Parnes

❮ Previous
Next ❯

Citations

Mar 17, 2010·Amino Acids·Xin LinXiaoyuan Chen
May 8, 2013·Pharmaceutical Research·Vera BrinksWim Jiskoot
Feb 27, 2001·Journal of Immunological Methods·K SundarapandiyanR F Graziano
Jul 25, 2000·Immunopharmacology·A Sahu, J D Lambris
Jun 20, 2003·Progress in Lipid Research·P Sapra, T M Allen
Feb 11, 2003·Journal of Neuroimmunology·Maurice H W StassenMarc H De Baets
Aug 1, 2000·Immunology Today·M LittleG Moldenhauer
Feb 5, 2003·Advanced Drug Delivery Reviews·Ying Cao, Laura Lam
Dec 17, 2002·Current Opinion in Biotechnology·Sirid Aimée Kellermann, Larry L Green
Aug 1, 1997·Current Opinion in Biotechnology·P Carter, A M Merchant
Aug 1, 1997·Current Opinion in Biotechnology·M Brüggemann, M J Taussig
Jul 27, 2001·Current Opinion in Chemical Biology·M A van Dijk, J G van de Winkel
Jul 13, 2011·Nature Biotechnology·Jacqueline M BensonMary A Mascelli
Jun 13, 1998·Nature Biotechnology·T J VaughanP R Tempest
Jul 1, 1996·Nature Biotechnology·M Neuberger
Sep 3, 2002·Nature Biotechnology·Yann Echelard, Harry Meade
Aug 30, 2005·Nature Biotechnology·Lei ZhuRobert J Etches
Sep 10, 2005·Nature Biotechnology·Nils Lonberg
Apr 17, 2007·Nature Biotechnology·Yariv MazorGeorge Georgiou
Jan 26, 2007·Nature Reviews. Cancer·Ignacio MeleroLieping Chen
Nov 17, 2005·Oncogene·Jin Q ChengSanto V Nicosia
Apr 12, 2002·Cloning and Stem Cells·R J Wall
May 15, 2002·Cloning and Stem Cells·Isao IshidaNils Lonberg
May 7, 1998·Microbiology and Immunology·I IshidaK Tomizuka
Oct 19, 2004·Clinical Microbiology Reviews·Saul TziporiHoward Trachtman
Sep 14, 2002·Infection and Immunity·Jean MukherjeeSaul Tzipori
Nov 10, 2001·Annual Review of Biomedical Engineering·J Maynard, G Georgiou
Mar 13, 2001·Annual Review of Immunology·M Feldmann, R N Maini
Nov 18, 2003·The Journal of Clinical Investigation·Louise S VilladsenJan G J van de Winkel
Dec 7, 2007·The Journal of Clinical Investigation·Dhaya SeshasayeeFlavius Martin
Feb 3, 2011·Fibrogenesis & Tissue Repair·Qingjian WangDavid Yeowell
Jan 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·K TomizukaI Ishida
Sep 14, 2010·Bioscience, Biotechnology, and Biochemistry·Tsukasa FujikiYoshinori Katakura
Nov 9, 2006·Archives of Dermatological Research·L S VilladsenO Baadsgaard
Mar 3, 2010·Cellular and Molecular Life Sciences : CMLS·Tomaz Bratkovic
Jan 11, 2003·Biotechnology & Genetic Engineering Reviews·Isao IshidaYoshimi Kuroiwa
Jan 27, 2016·Expert Opinion on Drug Metabolism & Toxicology·Yoshiya TanakaDaniel Baker
May 15, 2008·Expert Opinion on Biological Therapy·Siao-Yi Wang, George Weiner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Artificial Chromosomes

Artificial chromosomes are genetically engineered chromosomes derived from the DNA of a species. Discover the latest research on artificial chromosomes here.